Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-09-08 Sale | 2026-09-08 6:08 pm | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $16.46 | $41,142 | 291,647 (Direct) | View |
| 2026-08-03 Sale | 2026-08-03 6:14 pm | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $16.01 | $40,029 | 294,147 (Direct) | View |
| 2026-07-08 Sale | 2026-07-08 6:49 pm | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $16 | $40,000 | 296,647 (Direct) | View |
| 2026-06-30 Sale | 2026-07-01 7:04 pm | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 10,000 | $16.01 | $160,080 | 417,564 (Direct) | View |
| 2026-02-24 Sale | 2026-02-26 4:40 pm | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 7,100 | $16.02 | $113,728 | 259,488 (Direct) | View |
| 2026-02-11 Sale | 2026-02-13 4:27 pm | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 400 | $16 | $6,400 | 142,971 (Direct) | View |
| 2024-09-11 Purchase | 2024-09-12 06:32 am | KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director | 1,250 | $3.68 | $4,600 | 1,250 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-09-08 Exercise | 2026-09-08 6:08 pm | N/A 2030-02-24 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $0 | 291,647 (Direct) | View |
| 2026-09-08 Exercise | 2026-09-08 6:08 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $1.01 | 291,647 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 6:14 pm | N/A 2030-02-24 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $0 | 294,147 (Direct) | View |
| 2026-08-03 Exercise | 2026-08-03 6:14 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $1.01 | 294,147 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-08 6:49 pm | N/A 2030-02-24 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $0 | 296,647 (Direct) | View |
| 2026-07-08 Exercise | 2026-07-08 6:49 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $1.01 | 296,647 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-01 7:04 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 2,500 | $1.26 | 417,564 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-01 7:04 pm | N/A 2030-02-24 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 10,000 | $0 | 417,564 (Direct) | View |
| 2026-06-30 Exercise | 2026-07-01 7:04 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 7,500 | $1.01 | 417,564 (Direct) | View |
| 2026-06-10 Option Award | 2026-06-12 4:16 pm | 2027-06-10 2036-06-10 | KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2026-02-24 Exercise | 2026-02-26 4:40 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 7,100 | $1.26 | 259,488 (Direct) | View |
| 2026-02-24 Exercise | 2026-02-26 4:40 pm | N/A 2028-11-13 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 7,100 | $0 | 259,488 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 4:27 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 400 | $1.26 | 142,971 (Direct) | View |
| 2026-02-11 Exercise | 2026-02-13 4:27 pm | N/A 2028-11-13 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 400 | $0 | 142,971 (Direct) | View |
| 2026-01-30 Option Award | 2026-01-30 4:56 pm | N/A 2036-01-29 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 445,000 | $0 | 445,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-02 8:11 pm | 2026-04-01 2035-04-01 | KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-01-31 Option Award | 2025-01-31 4:35 pm | N/A 2035-01-30 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-07-01 Option Award | 2024-07-03 3:16 pm | 2025-07-01 2034-07-01 | KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director | 1,778 | $0 | 1,778 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-29 5:59 pm | N/A 2034-05-23 | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 285,000 | $0 | 285,000 (Direct) | View |
Ownership | 2024-04-04 5:49 pm | N/A N/A | Contineum Therapeutics Inc. | CTNM | Stengone Carmine N. CEO and President | 0 | $0 | 981,519 (Direct) | View |
| 2023-09-29 Option Award | 2023-10-03 4:45 pm | N/A 2033-09-29 | KIORA PHARMACEUTICALS INC | KPRX | Stengone Carmine N. Director | 8,000 | $0 | 8,000 (Direct) | View |